WebSerum TPS and PSA levels were determined in 128 patients (pts) with benign prostatic hypertrophy (BPH; Group 1) and in 92 pts with prostate cancer (Group 2). TPS was also measured in a control group of 100 healthy subjects. Normal cutoff values of 85 U/l for TPS and 4 ng/ml for PSA were determined on the basis of ROC curve analysis. WebThis phase III trial uses the Decipher risk score to guide intensification (for higher Decipher gene risk) or de-intensification (for low Decipher gene risk) of treatment to better match therapies to an individual patient's cancer aggressiveness. The Decipher risk score evaluates a prostate cancer tumor for its potential for spreading. In patients with low risk …
Beta-sitosterols for benign prostatic hyperplasia - PubMed
WebMay 15, 2008 · A randomized trial of medical therapies for patients with moderate to severe BPH showed that the placebo group had clinical progression (i.e., a four-point or more … WebBenign prostatic hyperplasia (BPH) may be a normal part of the aging process in men, but it can negatively affect the quality of life for your patients. Our portfolio includes innovative … down coats moncler
Beta-sitosterols for benign prostatic hyperplasia - PubMed
WebJun 27, 2024 · The first procedure with the novel ProVee System has been successfully completed in the pivotal ProVIDE trial, according to ProVerum Limited, the company developing the nitinol expander device for patients with benign prostatic hyperplasia (BPH). 1 According to ProVerum, “ProVee is a self-expanding implant that, once … WebOne of the most common surgical procedures for treating BPH, during TURP a surgeon removes prostate tissue using a special loop of wire through which an electric current … Web2 days ago · April 11, 2024. Alicia Morgans and Oliver Sartor discuss the latest developments and changes in the advanced prostate cancer landscape. Dr. Sartor mentions that novel hormones are used as first-line treatment in most cases and that the controversy … down coats made in usa